Compound ID | 3548

Update compound information

GSK839

Class: Tryptophan synthase inhibitor

Details of activity: Active against Mycobacterium tuberculosis; tryptophan synthase inhibitor (TrpAB inhibitor)
Description: Synthetic compound; a tetrazole benzene sulfonamide
Institute where first reported: GlaxoSmithKline
Highest developmental phase: Preclinical
Development status: Experimental
Chemical structure(s):
Click here for structure editor
Molecular weight: 378.38
Iso. SMILES: C1=CC(=CC=C1C2=NN(N=N2)CC3=NC=C(C=C3)F)S(=O)(=O)NCCO
InChI Key: ZADGDPAVPJLDBU-UHFFFAOYSA-N
Can. SMILES: C1=CC(=CC=C1C2=NN(CC3=CC=C(C=N3)F)N=N2)S(=O)(=O)NCCO
InChI: InChI=1S/C15H15FN6O3S/c16-12-3-4-13(17-9-12)10-22-20-15(19-21-22)11-1-5-14(6-2-11)26(24,25)18-7-8-23/h1-6,9,18,23H,7-8,10H2
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/137499806
Citation: https://www.newtbdrugs.org/pipeline/compound/gsk839

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.